Campbell & CO Investment Adviser LLC Purchases Shares of 19,047 Select Medical Holdings Co. (NYSE:SEM)

Campbell & CO Investment Adviser LLC purchased a new stake in Select Medical Holdings Co. (NYSE:SEMFree Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 19,047 shares of the health services provider’s stock, valued at approximately $448,000.

Several other institutional investors and hedge funds also recently modified their holdings of SEM. Vanguard Group Inc. lifted its stake in shares of Select Medical by 0.5% during the third quarter. Vanguard Group Inc. now owns 12,005,302 shares of the health services provider’s stock valued at $303,374,000 after buying an additional 64,373 shares during the period. Dimensional Fund Advisors LP raised its stake in Select Medical by 1.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 4,431,681 shares of the health services provider’s stock worth $104,147,000 after purchasing an additional 48,300 shares during the period. Victory Capital Management Inc. raised its stake in Select Medical by 15.7% during the fourth quarter. Victory Capital Management Inc. now owns 1,739,361 shares of the health services provider’s stock worth $40,875,000 after purchasing an additional 235,964 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Select Medical by 5.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,467,109 shares of the health services provider’s stock worth $34,477,000 after purchasing an additional 79,907 shares during the period. Finally, Norges Bank purchased a new position in Select Medical during the fourth quarter worth approximately $34,320,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Benchmark reaffirmed a “buy” rating and set a $39.00 price target on shares of Select Medical in a research note on Friday, May 3rd. Royal Bank of Canada increased their price target on shares of Select Medical from $36.00 to $40.00 and gave the stock an “outperform” rating in a research note on Monday, May 6th. Finally, StockNews.com raised shares of Select Medical from a “hold” rating to a “buy” rating in a research note on Friday, March 22nd. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $34.25.

View Our Latest Analysis on SEM

Select Medical Price Performance

Select Medical stock opened at $33.27 on Tuesday. Select Medical Holdings Co. has a 52-week low of $21.28 and a 52-week high of $35.08. The firm has a fifty day moving average of $31.08 and a 200-day moving average of $27.93. The firm has a market capitalization of $4.33 billion, a P/E ratio of 15.84, a PEG ratio of 1.59 and a beta of 1.44. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 2.30.

Select Medical (NYSE:SEMGet Free Report) last released its quarterly earnings data on Thursday, May 2nd. The health services provider reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.55 by $0.22. The company had revenue of $1.79 billion during the quarter, compared to analyst estimates of $1.70 billion. Select Medical had a net margin of 3.97% and a return on equity of 18.11%. As a group, analysts predict that Select Medical Holdings Co. will post 2.1 EPS for the current year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, May 30th. Investors of record on Thursday, May 16th were issued a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date of this dividend was Wednesday, May 15th. Select Medical’s payout ratio is 23.81%.

Insider Activity at Select Medical

In related news, Chairman Robert A. Ortenzio sold 50,000 shares of the firm’s stock in a transaction on Monday, April 8th. The shares were sold at an average price of $29.90, for a total transaction of $1,495,000.00. Following the completion of the sale, the chairman now directly owns 6,689,668 shares of the company’s stock, valued at approximately $200,021,073.20. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 17.50% of the company’s stock.

Select Medical Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.